📈 Free macro insights every week — Subscribe Free →
📈 Free macro insights every week — Subscribe Free →

MacroHint

Uncategorized

Michael from MacroHint Podcast Appearance!

Podcast Appearance! I am excited to be featured on the Vision Pros Podcast with H. Jackson Calame! It will be a conversation focused on entrepreneurship, leadership, and many other exciting topics. First Class Business Be sure to tune in this TODAY at 2:00 PM (CST)! hashtag#entrepreneurtips hashtag#entrepreneurialsuccess hashtag#entrepreneurship hashtag#business hashtag#podcast hashtag#atx hashtag#finance Michael LazenbyMichael Lazenby

Michael from MacroHint Podcast Appearance! Read More »

Stock Analysis: Rocket Pharmaceuticals (NASDAQ: RCKT)

This article is proudly sponsored by Skydive Spaceland, a skydiving venue with locations in Texas, Florida and Georgia! About Rocket Pharmaceuticals You know, as time has continued dribbling by, we have become increasingly annoyed by the term “clinical-stage” within the context of stock analysis articles on specialty pharmaceutical and biotechnology companies. Heck, we are just

Stock Analysis: Rocket Pharmaceuticals (NASDAQ: RCKT) Read More »

Stock Analysis: Baxter International (NYSE: BAX)

This article is proudly sponsored by Lake Region State College! About Baxter International Shoutout to Lee Ainslie, founder of Dallas-based hedge fund Maverick Capital and my university’s investment corporation, UTIMCO, for the inspiration for today’s article. If I am ever in the market for some inspiration regarding which companies or stocks I should analyze next,

Stock Analysis: Baxter International (NYSE: BAX) Read More »

Stock Analysis: Lam Research (NASDAQ: LRCX)

This article is proudly sponsored by Wee’s Cozy Kitchen, one of Austin’s premier Asian dining establishments! About Lam Research Who says one cannot become wealthy through academia? Boof, we say to that, as the founder of Lam Research, David K. Lam himself started out doing rather intense and insightful research within the nuclear physics arena

Stock Analysis: Lam Research (NASDAQ: LRCX) Read More »